PDCD1 and lung carcinoma: Recently, radiomics has been applied to the analysis of PD-1/PD-L1 expression in lung cancer, breast cancer, etc.30,44–50, but has rarely been applied to studies of the PD-1/PD-L1 expression status in HCC51–53.